Our Leadership

Bill W. Massey

Chief Scientific Officer

Bill Massey is a world-renowned neuropharmacologist, pharmacogeneticist and researcher. He has held senior executive positions at Merck, Astra Merck, AstraZeneca, and Quintiles, and academic appointments at The University of Chicago Pritzker School of Medicine and Vanderbilt University Medical School, where he held the Jack Martin, MD Professorship in Psychopharmacology. Dr. Massey currently holds adjunct faculty appointments at Northwestern University and the University of Arkansas for Medical Sciences. He is a board member of several biotechnology companies and research institutes.

Dr. Massey is recognized for his work in schizophrenia, antipsychotic drug development, pharmacogenetics, and infectious disease. He is an Editor for multiple scientific journals, including Frontiers in Microbiology. Dr. Massey continues to conduct and publish globally recognized research and scientific papers in the areas of neuropharmacology, mental illness, pharmacogenetics, molecular diagnostics, coordinated diagnostics, and drug addiction.

Scroll to Top